What is the long-term trend for Ocular Therapeutix's net interest and investment income (loss)?

Over 4 years (2021 to 2025), Ocular Therapeutix's net interest and investment income (loss) has grown at a 385.6% compound annual growth rate (CAGR), from $33K to $18.35M.

Ocular Therapeutix OCUL Net interest and investment income (loss)

Net interest and investment income (loss) at other companies

Axsome TherapeuticsAXSM

——

Segments

By segment

See full

Single Reportable$6.05M+58.1%

Other financials

Income statement

See full

Revenue$10.8M+0.8%

Gross profit$9.5M+0.2%

Operating income-$93.3M-46.0%

Net income-$88.6M-38.3%

EPS (diluted)-$0.40-5.3%

Balance sheet

See full

Cash & equivalents$666.7M+90.7%

Total debt$79.5M+4.2%

Total equity$581.6M+119%

Total assets$732.5M+80.5%

Cash flow

See full

Operating cash flow-$66.0M-47.7%

CapEx$4.7M+141%

Free cash flow-$70.7M-51.6%

Valuation

See full

Market cap$2.21B+58.2%

Enterprise value$1.63B+40.8%

P/S42.6×+19.1×

Profitability

See full

Gross margin87.2%-3.4pp

Operating margin-575.4%+1,233pp

Net margin-558.2%+1,493pp

FCF margin-463%+2,860pp

Returns & leverage

See full

Return on equity-68.6%+17.0pp

Debt / equity0.1×-0.2×

Current ratio14.8×+4.6×

Where this comes from

Reported directly by Ocular Therapeutix in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeNet.

The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ocular Therapeutix's net interest and investment income (loss).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ocular Therapeutix's net interest and investment income (loss)?: Ocular Therapeutix (OCUL) reported net interest and investment income (loss) of $6.05M in Q1 2026.
How has Ocular Therapeutix's net interest and investment income (loss) changed year-over-year?: Ocular Therapeutix's net interest and investment income (loss) increased by 58.1% year-over-year, from $3.83M to $6.05M.
What is the long-term trend for Ocular Therapeutix's net interest and investment income (loss)?: Over 4 years (2021 to 2025), Ocular Therapeutix's net interest and investment income (loss) has grown at a 385.6% compound annual growth rate (CAGR), from $33K to $18.35M.